Related Experiment Videos
[Endothelin and the cardiovascular system]
1A. A. Bogomolets Institute of Physiology, National Academy of Sciences of Ukraine, Kiev.
Fiziolohichnyi Zhurnal (Kiev, Ukraine : 1994)
|December 16, 1998
Summary
Endothelin (ET), a peptide from endothelial cells, strongly constricts blood vessels and impacts the heart. Inhibiting ET receptors may help treat cardiovascular diseases like hypertension and heart failure.
Area of Science:
- Cardiovascular Physiology
- Endocrinology
- Molecular Biology
Context:
- Endothelin (ET) is a potent peptide synthesized by various cardiovascular cells.
- ET production is stimulated by mechanical factors and specific cytokines (e.g., TNF-alpha).
- Elevated endogenous ET levels are observed in numerous cardiovascular pathologies.
Purpose:
- To elucidate the physiological roles and pathological significance of Endothelin.
- To investigate the therapeutic potential of Endothelin receptor inhibition.
Summary:
- Endothelin (ET) exhibits potent vasoconstrictive and positive inotropic effects.
- ET stimulates smooth muscle cell proliferation.
- Increased ET concentration is linked to systemic hypertension, myocardial infarction, vasospasm, and cardiac failure.
Impact:
- Endothelin receptor antagonists show promise in managing cardiovascular diseases.
- Understanding ET's role is crucial for developing novel therapeutic strategies.
- This research highlights ET as a key factor in cardiovascular homeostasis and disease pathogenesis.